LBX Pharmacy Chain JSC
SSE:603883
Intrinsic Value
LBX Pharmacy Chain JSC engages in the sale of medicine and health products. [ Read More ]
The intrinsic value of one LBX Pharmacy Chain JSC stock under the Base Case scenario is 63.61 CNY. Compared to the current market price of 29.52 CNY, LBX Pharmacy Chain JSC is Undervalued by 54%.
Valuation Backtest
LBX Pharmacy Chain JSC
Run backtest to discover the historical profit from buying and selling LBX Pharmacy Chain JSC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
LBX Pharmacy Chain JSC
Current Assets | 8.9B |
Cash & Short-Term Investments | 1.4B |
Receivables | 2.3B |
Other Current Assets | 5.3B |
Non-Current Assets | 12.1B |
Long-Term Investments | 459.1m |
PP&E | 4.4B |
Intangibles | 6.3B |
Other Non-Current Assets | 899.2m |
Current Liabilities | 10.2B |
Accounts Payable | 2.8B |
Accrued Liabilities | 500.1m |
Short-Term Debt | 4.4B |
Other Current Liabilities | 2.5B |
Non-Current Liabilities | 4.1B |
Long-Term Debt | 3.4B |
Other Non-Current Liabilities | 646.7m |
Earnings Waterfall
LBX Pharmacy Chain JSC
Revenue
|
22.4B
CNY
|
Cost of Revenue
|
-15.4B
CNY
|
Gross Profit
|
7.1B
CNY
|
Operating Expenses
|
-5.5B
CNY
|
Operating Income
|
1.6B
CNY
|
Other Expenses
|
-672.6m
CNY
|
Net Income
|
891.9m
CNY
|
Free Cash Flow Analysis
LBX Pharmacy Chain JSC
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
LBX Pharmacy Chain JSC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
LBX Pharmacy Chain JSC's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
LBX Pharmacy Chain JSC's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
LBX Pharmacy Chain JSC's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
LBX Pharmacy Chain JSC
According to Wall Street analysts, the average 1-year price target for LBX Pharmacy Chain JSC is 39.74 CNY with a low forecast of 27.88 CNY and a high forecast of 48.08 CNY.
Shareholder Return
Price
LBX Pharmacy Chain JSC
Average Annual Return | 8.37% |
Standard Deviation of Annual Returns | 22.99% |
Max Drawdown | -68% |
Market Capitalization | 17.2B CNY |
Shares Outstanding | 585 194 076 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
LBX Pharmacy Chain JSC engages in the sale of medicine and health products. The company is headquartered in Changsha, Hunan and currently employs 29,164 full-time employees. The company went IPO on 2015-04-23. The firm involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The firm also involves in wholesale and manufacture of drugs.
Contact
IPO
Employees
Officers
The intrinsic value of one LBX Pharmacy Chain JSC stock under the Base Case scenario is 63.61 CNY.
Compared to the current market price of 29.52 CNY, LBX Pharmacy Chain JSC is Undervalued by 54%.